🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🧬 Our study on molecular profiling of 99 cases of micropapillary urothelial carcinoma (MPUC): • Most common mutations: TP53, TERT, ARID1A, ERBB2 • ERBB2 alterations in 24%: Amplifications, Missense mutations (most common: p.S310F) • Only ERBB2 amplifications associated with:

Cindy Y. Jiang ASCO Conquer Cancer, the ASCO Foundation Omar Alhalabi, MD Congratulations Cindy Y. Jiang wonderful to see your hard work pay off. So excited for you join as faculty this summer!

🚨Noha N. Soror, MD, MSc. 𓂀 is presenting now our new Mentorship & Sponsorship committee!! #ASCO25 #IMGoncCoP Very exciting initiatives for upcoming #HemOnc fellowship applicants!! Join us in room S103!! ASCO ASCO TECAG OncoAlert Hem-Onc Fellows Network Oncology Brothers

🙏A badge of honor to wrap up my postdoc MD Anderson Cancer Center with two FY25 Q2 recognitions among🌟fellow trainees – (1) Our Practice-Informing Journal for ImmunoTherapy of Cancer Paper & (2) Conquer Cancer, the ASCO Foundation Merit Award #GU25. Thankful to mentors Matt Campbell MD, MS Omar Alhalabi, MD, & Sara Martinez for sharing!

Honored to introduce our new Mentorship & Sponsorship Committee, dedicated to supporting Hematology-Oncology fellowship applicants. Excited to help guide and uplift future leaders in our field. Grateful to #IMGoncCoP for entrusting me with this important initiative. Toni Choueiri, MD

Proud of #SamBlack a PGY2 joined by Mohammad Jad Moussa, MD, MSc incoming PGY1 BCMHouston BCM Department of Medicine (phenomenal BCM IM Residency) & our stellar fellow Cindy Y. Jiang MD Anderson Cancer Center presenting their work on HER2 (revealing HELQ, CDK12 and BCR mutations) in #bladdercancer at #ASCO25 ASCO

HUGE CONGRATS to my (future) co-resident Sam on this #ASCO25 feat! Thank you Dr. Alhalabi for your generous mentorship! Honored to follow in the footsteps of such accomplished residents BCM IM Residency; time for a GU Oncology Interest Group?🤔Kabir Grewal, MD Neha Venkatesh Sai Gajagowni

Amazing work presented by my friend and MD Anderson Cancer Center co-fellow Cindy Y. Jiang on the 9p21-loss story in bladder cancer. Targeting the TGFB pathway may be the path forward for improving outcomes in this aggressive cancer type! #ASCO25

Proud of our hem/onc fellow Cindy Y. Jiang (comentored with Linghua Wang, MD, PhD and #JJGao) advancing our understanding on #MTAPloss in #bladdercancer. We describe tropism to the lung and hypothesize signaling through TGFb/SMAD3.

🚨 important study. Running randomized controlled diet studies is really difficult bcz you provide the day meals to both arms and you control the snacks too. Even though it’s not easy to be on a high fiber diet, the data seems supportive ⏫IO efficacy and ⏬tox! #youarewhatyoueat

One slide. One shift in standard of care: 🫁 Tarlatamab (anti-DLL3xCD3) improves OS in 2L SCLC. #ASCO25 #SCLC #oncology #immunotherapy @oncoalert ASCO IASLC Vivek Subbiah, MD LARVOL 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 Oncology Brothers TwoOncDocs Christian Rolfo

Agree! Was a great discussion. Congrats to my colleague Jacqueline T. Brown, MD!

🧵1/ T cells have deservedly been in the🔦for #cancer #immunotherapy, but other engineered cell therapies are now📈. What mediates NK cell exhaustion remains an important unanswered❓. 📄Link: nature.com/articles/s4158… I’m so thrilled🥳to share our work out now🚨nature

🎉 One of our FAVORITE events of the year, moving for 81’ in beautiful Hermann Park #Houston for the KCA’s 81K Fundraising Challenge! Thank you Matt Campbell MD, MS for leading our #BoneMets Team MD Anderson Cancer Center; KCA leadership Gretchen Vaughan & team for organizing this event!

🚨Calling all mentors! We’re launching a mentorship program to support applicants to Hem/Onc fellowship programs! ✅Are you a current fellow or faculty? ✅Interested in guiding future Hem/Onc leaders? 👉Sign up here: tinyurl.com/ykw9pmuv OncoAlert ASCO TECAG Hem-Onc Fellows Network

Mohamed Ali OncoAlert ASCO TECAG Hem-Onc Fellows Network Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc Noha N. Soror, MD, MSc. 𓂀 Omar Alhalabi, MD Sarbajit Mukherjee Amer Zeidan MBBS,MHS ‏عامر زيدان Vivek Subbiah, MD Charu Aggarwal, MD, MPH, FASCO Arya Roy We will open the sign-up process for mentees once we have a better understanding of mentor availability! We’ll be posting updates! 🙌

✍️Mark your calendar for our next upcoming space‼️ Conquer Conversations; Navigating Career Development with Conquer Cancer Support🏆 Speaker: Julia Schwartz/Conquer Cancer, the ASCO Foundation Host: Noha N. Soror, MD, MSc. 𓂀 ⏰Tuesday, 1st July, 2025 📍Zoom, 17:30 pm EST (Scan QR code for registration)

First trial of PD1/VEGF bispecific in #kidneycancer just activated today and is Nazli Dizman’s trial design project during her MD Anderson Cancer Center heme/onc fellowship 🤓 👉 clinicaltrials.gov/study/NCT06940… Brian Rini, MD Sumanta K. Pal, MD, FASCO Andy Hahn Omar Alhalabi, MD Matt Campbell MD, MS Chad Tang, MD Sangeeta Goswami, MD,PhD

Chad Tang, MD & I happy to report: ph2 basket EXTEND-OP trial has enrolled and randomized 150 patients in the last year since opening: - 7 histology-specific baskets - Oligoprogressive dz randomized to: ☢ Local Tx + continued same-line systemic, versus 💊Switching systemic Tx

Yup what a ride. Still got a some more to go. Appreciate our study team, our awesome med oncs who support the trial Pavlos Msaouel Andy Hahn Omar Alhalabi, MD (many more not on X), and of course our patients.